Kidney stones can take anywhere from a few weeks to several years to form, depending on the type of stone, the chemistry of your urine, and your underlying health. The most common variety, calcium oxalate stones, typically develop over months to years as crystals slowly accumulate on tiny calcium deposits deep inside the kidney. But infection-related stones and drug-induced crystals can appear far faster, sometimes within days or weeks. The timeline is less like a countdown and more like a set of conditions that, once aligned, let mineral buildup accelerate or stall.
Where Stones Actually Begin
A kidney stone does not simply pop into existence. It starts as a microscopic event called nucleation, where dissolved minerals in your urine cluster together tightly enough to form a tiny crystal seed. The driving force behind this is supersaturation: when the concentration of stone-forming minerals in your urine exceeds what the liquid can hold in solution, crystals become thermodynamically favorable. In practice, though, crystals almost never form spontaneously out of thin air in the kidney. Instead, they tend to latch onto an existing surface, which dramatically lowers the energy needed to start growing.
For most calcium oxalate stone formers, that surface is something called Randall’s plaque, a layer of calcium phosphate that accumulates in the tissue lining the tips of the kidney’s internal structures (the renal papillae). These plaques begin as deposits so small they can only be seen with electron microscopy, starting in the basement membranes of tiny kidney tubes called the thin loops of Henle, with individual deposits as small as 50 nanometers.1JCI Insight. Randall’s plaque of patients with nephrolithiasis begins in basement membranes of thin loops of Henle These initial deposits form without any visible damage to the surrounding cells, which is part of why the earliest stages of stone formation are completely silent.
Large amounts of Randall’s plaque are a hallmark of people who form calcium oxalate stones, and the plaque is considered a prerequisite for this type of stone in many patients.2PubMed Central. The role of Randall plaques on kidney stone formation The plaque itself may build up over years before a stone ever forms on top of it. So the answer to “how fast” partly depends on where you start counting. The plaque accumulation phase is slow and invisible. The stone growth phase that follows can be faster, but still measured in months for calcium oxalate.
The Slow Path for Calcium Oxalate Stones
When Randall’s plaque breaks through the tissue surface and becomes exposed to urine, it acts as a landing pad. Calcium and oxalate ions from the urine begin depositing onto the exposed plaque, initially forming thin layers of crystal and organic material. Gradually, calcium phosphate crystals give way to calcium oxalate crystals, which become the dominant mineral phase of the growing stone.3PubMed. Mechanism of formation of human calcium oxalate renal stones on Randall’s plaque This layered growth process is slow and incremental, with urine chemistry fluctuating day to day based on hydration, diet, and metabolic factors.
At the molecular level, researchers have observed that calcium oxalate monohydrate (the most common crystal type in kidney stones) grows through a stepwise process where ions first land on the flat crystal surface, then migrate across it before locking into position at step edges on the crystal.4PubMed Central. Mechanistic Pathways for the Molecular Step Growth of Calcium Oxalate Monohydrate Crystal Revealed by In Situ Liquid-Phase Atomic Force Microscopy That surface-migration step is what limits the overall growth speed. It means that even when urine is heavily supersaturated, the crystal can only grow so fast because ions have to physically find their way to the right spot on the surface.
In practical terms, calcium oxalate stones commonly take months to years to reach a size that causes symptoms. Many small stones sit quietly in the kidney for extended periods. One study tracking asymptomatic, nonobstructing stones found that a small fraction caused painless obstruction over an average of about three years of observation.5PubMed. The natural history of nonobstructing asymptomatic renal stones managed with active surveillance This slow timeline is the norm for calcium-based stones in otherwise healthy people.
The Fast Path for Infection Stones
Struvite stones, sometimes called infection stones, play by entirely different rules. They form when certain bacteria in the urinary tract produce an enzyme called urease, which splits urea into ammonia. The ammonia raises urine pH sharply, and in that alkaline environment, magnesium ammonium phosphate (struvite) crystallizes readily. These stones have the potential for rapid growth and can become very large in a matter of weeks.6PubMed Central. Intravesical vancomycin for the treatment of Corynebacterium cystitis and struvite bladder stones: A case report
Struvite stones are the type most associated with “staghorn” stones, those large, branching masses that fill the entire interior space of the kidney. The speed comes from the fact that the bacterial infection continuously pumps ammonia into the urine, keeping conditions ideal for crystallization around the clock. As long as the infection persists, the stone keeps growing. Eradicating the bacteria is difficult because they can colonize both the urinary lining and the stone itself, creating a protected reservoir. This is why struvite stones often require both surgical removal and antibiotic treatment, and even then, fragments left behind can seed regrowth if the infection returns.
Because the timeline depends on the infection rather than on gradual mineral supersaturation, struvite stones can go from nonexistent to clinically significant in timeframes that would be impossible for calcium oxalate. A persistent, untreated urinary tract infection with a urease-producing organism is the key accelerant. People with chronic catheter use, neurogenic bladder conditions, or recurrent UTIs are at highest risk.
Drug-Induced Stones Can Appear in Days
Some medications create an entirely different and sometimes startlingly fast form of stone or crystal deposit. When certain drugs are excreted through the kidneys at high concentrations, they can crystallize directly in the urine. The drug itself becomes the stone material. Medications known to do this include sulfonamide antibiotics, ciprofloxacin, the antiviral indinavir, the diuretic triamterene, and others.7PubMed Central. Drug-induced urinary calculi – Section: Abstract
In the most acute cases, drugs like acyclovir, methotrexate, and sulfonamides can precipitate inside the kidney tubules themselves, causing sudden crystal-induced kidney injury.8PubMed. Crystal-induced acute renal failure This is not the same gradual buildup seen with diet-related stones. It can happen within hours to days of starting or increasing a dose, particularly if you are dehydrated or if the drug concentration in the urine spikes. The damage can be severe enough to cause acute kidney failure.
Indinavir, an older HIV medication, is a well-known example. Patients taking it at standard doses sometimes developed radiolucent stones (stones that do not show up well on X-rays) within weeks of starting therapy, especially if they were not drinking enough fluid. While indinavir has largely been replaced by newer antiretrovirals, the lesson holds for newer medications that may carry similar risks. Staying well hydrated during treatment with any of these drugs is the single most effective preventive measure, because diluting the urine reduces the chance the drug will reach the concentration needed to crystallize.
Uric Acid Stones and the Role of pH
Uric acid stones form through a mechanism that is distinct from calcium-based stones. The main culprit is not high uric acid levels in the urine (though that contributes) but rather an abnormally low urine pH.9PubMed. Studies on the pathophysiology of the low urine pH in patients with uric acid stones Uric acid is moderately soluble in urine at normal pH (around 6.0 to 6.5), but its solubility drops dramatically when pH falls below about 5.5. In acidic urine, even normal amounts of uric acid can crystallize.
Low urine volume compounds the problem.10PubMed Central. Uric Acid Nephrolithiasis: A Systemic Metabolic Disorder – Section: Abstract People who are chronically dehydrated, those with metabolic syndrome or type 2 diabetes (both of which tend to lower urine pH), and those who eat diets very high in animal protein are the classic risk group. Gout patients are also at elevated risk, since they already produce more uric acid than average.
The formation speed for uric acid stones is variable but can be faster than for calcium oxalate. Because the crystallization is driven primarily by pH and volume rather than by the gradual buildup of plaque infrastructure, uric acid stones can form relatively quickly when conditions align: a period of dehydration, heavy protein intake, or an acute gout flare can tip the balance. On the encouraging side, uric acid stones are the only common stone type that can sometimes be dissolved by correcting the urine pH with oral alkali therapy, which means they can also shrink rather than only grow.
Genetic Conditions That Accelerate Everything
For most people, stone formation is a slow, occasional process driven by lifestyle and dietary factors. But certain inherited conditions can dramatically compress the timeline by flooding the urine with stone-forming substances from birth.
Primary hyperoxaluria is one of the most severe. It is a group of rare inherited disorders in which the liver overproduces oxalate because of defective enzymes in glyoxylate metabolism. The excess oxalate pours into the urine and can cause massive stone formation and calcium oxalate deposits throughout the kidney tissue. As kidney function declines (particularly once filtration drops below about 30 to 45 mL/min), oxalate begins depositing in other organs including bone, skin, the retina, and the cardiovascular system, a condition called systemic oxalosis.11American Journal of Kidney Diseases. Hyperoxaluria: The Gate to Oxalate Nephropathy – Section: Primary Hyperoxaluria Children with the most severe form (type 1) can develop their first stones in infancy and form them recurrently throughout life.
Cystinuria is another genetic condition that leads to recurrent stone formation starting in childhood or adolescence. People with cystinuria excrete abnormally high levels of the amino acid cystine in their urine, and cystine is poorly soluble, so it crystallizes readily. Like primary hyperoxaluria, cystinuria means the raw material for stones is always present in excess, and stones form far more frequently and predictably than in the general population.
In these conditions, the question shifts from “how fast can a stone form” to “how fast does the next one form after the last one was removed.” The answer is often distressingly fast, weeks to months, because the underlying metabolic abnormality is always running.
What Slows Stones Down
Your urine is not just a passive container for minerals. It contains a lineup of natural inhibitors that actively interfere with crystal nucleation and growth. Citrate is the best-studied: it binds to calcium in the urine, reducing the amount of free calcium available to pair with oxalate, and it directly inhibits crystal growth on existing surfaces. People with low urinary citrate levels have a significantly higher incidence of calcium phosphate and calcium oxalate stones.12PubMed Central. Citrate salts for preventing and treating calcium containing kidney stones in adults – Section: Abstract
Beyond citrate, other inhibitors include magnesium, zinc, and a group of proteins in the urine such as uromodulin (also called Tamm-Horsfall protein), osteopontin, and nephrocalcin.13PubMed Central. Kidney stone matrix proteins: Role in stone formation These molecules coat crystal surfaces, block growth sites, and can even prevent crystals from sticking to the kidney lining. In a sense, everyone’s urine is in a constant tug-of-war between the forces that promote crystallization (high mineral concentrations, low volume, extreme pH) and the forces that suppress it (inhibitor molecules, adequate hydration, moderate pH).
Oral citrate therapy illustrates how much these inhibitors matter for stone growth speed. In one study, supplementation with alkali citrate reduced the crystal growth rate of calcium oxalate in urine by about 70%, with roughly half of that effect coming from reduced calcium excretion and the rest from the direct inhibitory action of citrate and the accompanying pH change.14PubMed. The in-vivo effect of sodium-potassium citrate on the crystal growth rate of calcium oxalate and other parameters in human urine A 70% reduction in crystal growth rate does not just slow down an existing stone; it can be the difference between forming a new stone and not forming one at all.
Why Stones Can Seem to Appear Out of Nowhere
Many people experience their first episode of renal colic as a sudden emergency, which creates the impression that the stone formed quickly. In reality, the stone was likely growing for months or years before it detached or shifted into the ureter and caused pain. Stones sitting quietly in the kidney’s collecting system can be completely asymptomatic for extended periods. They only announce themselves when they move into a narrow passage and obstruct urine flow.
This disconnect between formation time and symptom onset is one of the most common misunderstandings about kidney stones. A patient who was fine on Monday and in the emergency room on Tuesday did not form a stone overnight. They probably had a stone growing slowly for a long time, and it just happened to migrate on Tuesday. Tracking studies of asymptomatic stones confirm this pattern: most sit quietly for years, and a small percentage cause obstruction silently, without any pain at all, sometimes discovered only when imaging is done for an unrelated reason.5PubMed. The natural history of nonobstructing asymptomatic renal stones managed with active surveillance
The exception is the drug-induced and infection-driven scenarios described earlier, where rapid crystallization can genuinely produce a stone or crystal mass in a short timeframe. But for the garden-variety calcium stone, the “suddenness” is about the symptom, not the stone.
Regrowth After Treatment
The speed question also matters after a stone has been treated. Shock wave lithotripsy (SWL), the most common noninvasive treatment, breaks stones into fragments. Ideally those fragments pass out in the urine, but small residual pieces often remain. These fragments are not inert; they can serve as seeds for new crystal growth, essentially giving the stone a head start if the underlying urine chemistry has not changed.
In one study of patients treated with lithotripsy, about 10% showed regrowth of residual fragments. Regrowth was significantly more likely when the original stone was larger than 10 mm, with roughly a quarter of patients in that group experiencing fragment regrowth compared to just 2% of those whose original stone was smaller.15PubMed. Renal stone fragments following shock wave lithotripsy – Section: RESULTS This makes intuitive sense: bigger stones leave bigger fragments, and bigger fragments have more surface area for new crystal deposition.
This is part of why urologists emphasize metabolic evaluation and prevention strategies after a first stone episode. Removing the stone without addressing the chemistry that made it is like mopping water off the floor without fixing the leak. The fragments left behind, or entirely new nucleation sites, can seed the next stone on a timeline compressed by whatever risk factors remain in play. For someone who stays dehydrated, maintains a high-sodium diet, or has undiagnosed hypercalciuria, the second stone may come faster than the first because the metabolic conditions never actually changed.
Dehydration as the Universal Accelerant
Across every stone type and every formation mechanism, one variable shows up repeatedly: urine volume. When urine output drops, the concentration of every dissolved substance rises. That means higher supersaturation, more opportunity for crystals to nucleate, faster growth of existing crystals, and less dilution of inhibitors. Chronic low fluid intake is the single most modifiable risk factor for kidney stones regardless of composition.
The practical threshold most guidelines converge on is producing at least two liters of urine per day, which typically means drinking about two and a half to three liters of fluid daily, more if you sweat heavily. For someone who has already formed a stone, increasing fluid intake is the one intervention that has consistent evidence across stone types. It does not matter whether your stone was calcium oxalate, uric acid, or struvite: diluting the urine slows down the chemistry that drives crystal growth. It will not override a raging bacterial infection or a massive genetic oxalate overload, but for the average stone former, hydration is the cheapest and most effective way to lengthen the interval before the next stone and slow the growth of any stone already forming.